Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Cancer
Published in: Molecular Cancer 1/2008

Open Access 01-12-2008 | Erratum

Erratum to: Involvement of GTA protein NC2beta in Neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation

Authors: Cinzia Di Pietro, Marco Ragusa, Davide Barbagallo, Laura R Duro, Maria R Guglielmino, Alessandra Majorana, Veronica Giunta, Antonella Rapisarda, Elisa Tricarichi, Marco Miceli, Rosario Angelica, Agata Grillo, Barbara Banelli, Isabella Defferari, Stefano Forte, Alessandro Laganà, Camillo Bosco, Rosalba Giugno, Alfredo Pulvirenti, Alfredo Ferro, Karl H Grzeschik, Andrea Di Cataldo, Gian P Tonini, Massimo Romani, Michele Purrello

Published in: Molecular Cancer | Issue 1/2008

Login to get access

Excerpt

After publication of this work [1], we noticed that as Dr Rosario Angelica was added as an author late in the process, details were inadvertently omitted from the "Authors' contributions" and "Competing interests" sections of the article. These have now been modified accordingly. …
Literature
1.
Di Pietro Cinzia, Ragusa Marco, Barbagallo Davide, Duro Laura, Guglielmino Maria, Majorana Alessandra, Giunta Veronica, Rapisarda Antonella, Tricarichi Elisa, Miceli Marco, Grillo Agata, Banelli Barbara, Defferari Isabella, Forte Stefano, Laganà Alessandro, Bosco Camillo, Giugno Rosalba, Pulvirenti Alfredo, Ferro Alfredo, Grzeschik Karl, Di Cataldo Andrea, Tonini Gian, Romani Massimo, Purrello Michele: Involvement of GTA protein NC2beta in Neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation. Molecular Cancer. 2008, 7: 52- 10.1186/1476-4598-7-52PubMedCentralCrossRefPubMed
Metadata
Title
Erratum to: Involvement of GTA protein NC2beta in Neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation
Authors
Cinzia Di Pietro
Marco Ragusa
Davide Barbagallo
Laura R Duro
Maria R Guglielmino
Alessandra Majorana
Veronica Giunta
Antonella Rapisarda
Elisa Tricarichi
Marco Miceli
Rosario Angelica
Agata Grillo
Barbara Banelli
Isabella Defferari
Stefano Forte
Alessandro Laganà
Camillo Bosco
Rosalba Giugno
Alfredo Pulvirenti
Alfredo Ferro
Karl H Grzeschik
Andrea Di Cataldo
Gian P Tonini
Massimo Romani
Michele Purrello
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2008
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-7-59

Other articles of this Issue 1/2008

Molecular Cancer 1/2008 Go to the issue

Research

Rhabdomyosarcoma cells show an energy producing anabolic metabolic phenotype compared with primary myocytes

Research

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells

Research

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines

Research

Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer

Research

A conserved acidic patch in the Myb domain is required for activation of an endogenous target gene and for chromatin binding

Research

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits